bibliographic entry 11398863 [be/11398863]
https://w3id.org/oc/corpus/be/11398863

is a
content
  • Lin B, Koibuchi N, Hasegawa Y et al. Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice. Cardiovasc Diabetol 2014; 13: 148. PMID: 25344694
references